Indeed, Aurora-A overexpression has been associated in cancer cells with spindle checkpoint dysfunction, increased resistance to paclitaxel and docetaxel [28,29], increased expression of Bcl-2 [34] or of Bcl-xL [35]. This evidence concerns the gene BCL2L1 and cancer.